A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

By Bill P.A.   Vigonius U.   Pohlmann H.   Guerreiro C.A.M.   Kochen S.   Saffer D.   Moore A.  

Epilepsy Research, Vol. 27, Iss. 3, 1997-06 ,pp. : 195-204

Elsevier

Access to resources Recommend Favorite

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

By Guerreiro M.M.   Vigonius U.   Pohlmann H.   de Manreza M.L.G.   Fejerman N.   Antoniuk S.A.   Moore A.  

Epilepsy Research, Vol. 27, Iss. 3, 1997-06 ,pp. : 205-213

Elsevier

Access to resources Recommend Favorite

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

By Palhagen S.   Canger R.   Henriksen O.   van Parys J.A.   Riviere M.-E.   Karolchyk M.A.  

Epilepsy Research, Vol. 43, Iss. 2, 2001-02 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy

By Brodie M.J.   Overstall P.W.   Giorgi L.  

Epilepsy Research, Vol. 37, Iss. 1, 1999-10 ,pp. : 81-87

Elsevier

Access to resources Recommend Favorite

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy

By Brodie M.J.   Mumford J.P.  

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite